Currently, Olema Pharmaceuticals Inc [OLMA] is trading at $23.17, up 5.27%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The OLMA shares have gain 175.83% over the last week, with a monthly amount glided 186.40%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Olema Pharmaceuticals Inc [NASDAQ: OLMA] stock has seen the most recent analyst activity on October 08, 2025, when Guggenheim initiated its Buy rating and assigned the stock a price target of $20. Previously, Citigroup reaffirmed its Buy rating on August 12, 2025, and elevated its price target to $21. On April 02, 2024, Goldman initiated with a Buy rating and assigned a price target of $24 on the stock. Citigroup started tracking the stock assigning a Buy rating and suggested a price target of $20 on January 30, 2024. Oppenheimer initiated its recommendation with an Outperform and recommended $21 as its price target on July 21, 2023. CapitalOne started tracking with an Overweight rating for this stock on May 05, 2023, and assigned it a price target of $16. In a note dated February 22, 2023, Credit Suisse initiated an Outperform rating and provided a target price of $12 on this stock.
This stock has fluctuated between a low of $2.86 and a high of $27.17 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $34 within the next 12 months. Olema Pharmaceuticals Inc [NASDAQ: OLMA] shares were valued at $23.17 at the most recent close of the market. An investor can expect a potential return of 46.74% based on the average OLMA price forecast.
Analyzing the OLMA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.43, Equity is -0.42 and Total Capital is -0.53. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 21.03 points at the first support level, and at 18.90 for the second support level. However, for the 1st resistance point, the stock is sitting at 24.30, and for the 2nd resistance point, it is at 25.44.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Olema Pharmaceuticals Inc [NASDAQ:OLMA] is 8.03. Also, the Quick Ratio is 8.03, while the Cash Ratio stands at 0.85.
Transactions by insiders
Recent insider trading involved Harmon Cyrus, Director, that happened on Sep 18 ’25 when 10000.0 shares were sold. Director, Harmon Cyrus completed a deal on Sep 16 ’25 to sell 10000.0 shares. Meanwhile, Director Harmon Cyrus sold 3086.0 shares on Sep 18 ’25.
